4th Quarter - Report

BIOGEN for BIOGEN

Firm
Client
Income
—
Expenses
$266,680
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Corporate tax requirements and jobs: Domestic and international tax policies that protect and incentivize U.S. based research and manufacturing jobs including the net cost of Biogen R & D and well as percentage of revenue spent on R &D.

LobbyistCovered position, as disclosed
JONATHAN CAUSEY New Hon. Larry Bucshon - Chief of Staff, Senator Elizabeth Dole - Legislative Director--Hon. Patrick McHenry - Chief of Staff---Hon. Robin Hayes - Legislative Senator , Hon. Jesse Helms - Hon, Howard Coble
STEPHANIE A. DYSON Deputy Office Director, OSORA CMS Special Assistant, COO, CMS
JOHN RAYMOND GIBSON New —
MICHELLE MATHY New —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

IP protections for biologics and pharmaceuticals, consistent with U.S. law, to be included in trade agreements.

LobbyistCovered position, as disclosed
JONATHAN CAUSEY New Hon. Larry Bucshon - Chief of Staff, Senator Elizabeth Dole - Legislative Director--Hon. Patrick McHenry - Chief of Staff---Hon. Robin Hayes - Legislative Senator , Hon. Jesse Helms - Hon, Howard Coble
STEPHANIE A. DYSON New Deputy Office Director, OSORA CMS Special Assistant, COO, CMS
JOHN RAYMOND GIBSON —
MICHELLE MATHY New —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

S.1416 - Affordable Prescriptions for Patients Act of 2019 pertaining to the U.S. Patent system and well as patent law as it pertains to the IP system/process.SEC. 106. RESTORATION OF PATENTS AS PROPERTY RIGHTS. Entire Bill with particular emphasis on Secti 2, product hoping and patent thickening

LobbyistCovered position, as disclosed
JONATHAN CAUSEY New Hon. Larry Bucshon - Chief of Staff, Senator Elizabeth Dole - Legislative Director--Hon. Patrick McHenry - Chief of Staff---Hon. Robin Hayes - Legislative Senator , Hon. Jesse Helms - Hon, Howard Coble
STEPHANIE A. DYSON New Deputy Office Director, OSORA CMS Special Assistant, COO, CMS
JOHN RAYMOND GIBSON —
MICHELLE MATHY New —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1416 (116th)

Health Issues HCR

1. The Prescription Drug Pricing Reduction Act (PDPRA) of 2019 (entire bill) -- 2. H.R. 3, Lower Drug Costs Now Act of 2019 (entire bill 3. Biosimilars Policy (no Bill). Advocacy for policy supporting/ that will spur the entry of biosimilars into the United States that will provide the Headroom for Innovation and is additive to the drug pricing policy debate. 4. Prescription Pricing for People Act (S. 1227/H.R. 2376) -SEC. 3. STUDY OF PHARMACEUTICAL SUPPLY CHAIN INTERMEDIARIES AND MERGER ACTIVITY as it pertains to PBMS and the supply chain. 5. Drug Rebate regulation - (no Bill) -Discussion regarding the Administrations withdrawal Harmful Drug Rebate Safe Harbor Rule, CBO Estimates, 6. Issues related to state based Newborn Screening Programs and tests (no Bill) 7. S.2543 - Prescription Drug Pricing Reduction Act of 2019

LobbyistCovered position, as disclosed
JONATHAN CAUSEY New Hon. Larry Bucshon - Chief of Staff, Senator Elizabeth Dole - Legislative Director--Hon. Patrick McHenry - Chief of Staff---Hon. Robin Hayes - Legislative Senator , Hon. Jesse Helms - Hon, Howard Coble
STEPHANIE A. DYSON New Deputy Office Director, OSORA CMS Special Assistant, COO, CMS
JOHN RAYMOND GIBSON —
MICHELLE MATHY New —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3 (116th), H.R. 2376 (116th), S. 2543 (116th), S. 1227 (116th)

Medicare/Medicaid MMM

Issues related to changes in the Medicare Part B reimbursement system; issues related to changes in Iternational Pricing Index proposal; and Administration and Congressional proposal to address rebates in the Medicare Part D program the Prescription Drug Pricing Reduction Act (PDPRA) of 2019 andH.R. 3, Lower Drug Costs Now Act of 2019).

LobbyistCovered position, as disclosed
JONATHAN CAUSEY New Hon. Larry Bucshon - Chief of Staff, Senator Elizabeth Dole - Legislative Director--Hon. Patrick McHenry - Chief of Staff---Hon. Robin Hayes - Legislative Senator , Hon. Jesse Helms - Hon, Howard Coble
STEPHANIE A. DYSON New Deputy Office Director, OSORA CMS Special Assistant, COO, CMS
JOHN RAYMOND GIBSON —
MICHELLE MATHY New —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.